Acadian Asset Management LLC Genmab A/S Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Genmab A/S stock. As of the latest transaction made, Acadian Asset Management LLC holds 48,016 shares of GMAB stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,016

Previous 38,010 26.32%

Holding current value

$1.03 Million

Previous $954,000 22.54%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $238,543 - $284,970	10,006 Added 26.32%	48,016 $1.17 Million
Q2 2024 Aug 06, 2024	BUY	$25.13 - $30.27 $747,919 - $900,895	29,762 Added 360.84%	38,010 $954,000
Q1 2024 May 10, 2024	SELL	$26.43 - $32.77 $169,707 - $210,416	-6,421 Reduced 43.77%	8,248 $245,000
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $1.02 Million - $1.3 Million	-36,625 Reduced 71.4%	14,669 $466,000
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $800,629 - $958,848	-22,700 Reduced 30.68%	51,294 $1.81 Million
Q2 2023 Aug 07, 2023	SELL	$37.4 - $42.94 $369,923 - $424,719	-9,891 Reduced 11.79%	73,994 $2.81 Million
Q1 2023 May 11, 2023	SELL	$34.88 - $43.22 $3.33 Million - $4.13 Million	-95,467 Reduced 53.23%	83,885 $3.16 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $4.95 Million - $6.89 Million	146,365 Added 443.71%	179,352 $7.6 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $61,243 - $725,924	1,943 Added 6.26%	32,987 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $61,243 - $725,924	1,943 Added 6.26%	32,987 $1.06 Million
Q1 2022 May 12, 2022	SELL	$30.95 - $39.68 $1.16 Million - $1.48 Million	-37,368 Reduced 54.62%	31,044 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $45,247 - $53,056	1,089 Added 1.62%	68,412 $2.99 Million
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $2.21 Million - $3 Million	67,323 New	67,323 $2.75 Million
Q1 2021 May 11, 2021	SELL	$30.92 - $44.4 $17,748 - $25,485	-574 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$33.66 - $40.76 $268,034 - $324,571	-7,963 Reduced 93.28%	574 $23,000
Q3 2020 Nov 09, 2020	BUY	$33.07 - $38.68 $237,144 - $277,374	7,171 Added 524.96%	8,537 $313,000
Q2 2020 Aug 12, 2020	BUY	$20.05 - $33.89 $27,388 - $46,293	1,366 New	1,366 $46,000

Others Institutions Holding GMAB

# of Institutions

239

Shares Held

52.6M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.1B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Genmab A/S Transaction History